E Bucciarelli

1.3k total citations
48 papers, 1.0k citations indexed

About

E Bucciarelli is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, E Bucciarelli has authored 48 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Cancer Research and 12 papers in Pathology and Forensic Medicine. Recurrent topics in E Bucciarelli's work include Breast Cancer Treatment Studies (9 papers), HER2/EGFR in Cancer Research (6 papers) and Breast Lesions and Carcinomas (5 papers). E Bucciarelli is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), HER2/EGFR in Cancer Research (6 papers) and Breast Lesions and Carcinomas (5 papers). E Bucciarelli collaborates with scholars based in Italy, United States and United Kingdom. E Bucciarelli's co-authors include Angelo Sidoni, Guido Bellezza, Antonio Cavaliere, Massimo Scheibel, G. F. Rabotti, Albert J. Dalton, Ivana Ferri, Brunangelo Falini, Maurizio Tonato and V. Costantini and has published in prestigious journals such as The Journal of Cell Biology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

E Bucciarelli

47 papers receiving 925 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Bucciarelli Italy 19 419 311 244 210 157 48 1.0k
Larry Kluskens United States 18 466 1.1× 211 0.7× 209 0.9× 375 1.8× 172 1.1× 43 1.2k
K Mukai Japan 20 452 1.1× 153 0.5× 355 1.5× 436 2.1× 171 1.1× 41 1.3k
Black Mm United Kingdom 14 369 0.9× 259 0.8× 97 0.4× 202 1.0× 125 0.8× 47 900
E. L. Jones United Kingdom 21 302 0.7× 105 0.3× 192 0.8× 388 1.8× 186 1.2× 81 1.2k
Paul Drillenburg Netherlands 20 442 1.1× 196 0.6× 374 1.5× 350 1.7× 175 1.1× 37 1.4k
Frank B. Fromowitz United States 18 340 0.8× 175 0.6× 488 2.0× 171 0.8× 436 2.8× 40 1.2k
Torben Schiødt Denmark 18 398 0.9× 233 0.7× 96 0.4× 321 1.5× 327 2.1× 50 1.1k
Melek Ergin Türkiye 21 456 1.1× 227 0.7× 510 2.1× 346 1.6× 183 1.2× 89 1.5k
Abelardo Moreno Spain 22 397 0.9× 117 0.4× 311 1.3× 182 0.9× 153 1.0× 52 1.2k
Anita Borges India 24 599 1.4× 204 0.7× 390 1.6× 232 1.1× 274 1.7× 72 1.6k

Countries citing papers authored by E Bucciarelli

Since Specialization
Citations

This map shows the geographic impact of E Bucciarelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Bucciarelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Bucciarelli more than expected).

Fields of papers citing papers by E Bucciarelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Bucciarelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Bucciarelli. The network helps show where E Bucciarelli may publish in the future.

Co-authorship network of co-authors of E Bucciarelli

This figure shows the co-authorship network connecting the top 25 collaborators of E Bucciarelli. A scholar is included among the top collaborators of E Bucciarelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Bucciarelli. E Bucciarelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sidoni, Angelo, Ivana Ferri, Antonio Cavaliere, et al.. (2006). Detection of HER-2/neu (c-erbB-2) overexpression and amplification in breast carcinomas with ambiguous immunohistochemical results. A further contribution to defining the role of fluorescent in situ hybridization.. PubMed. 26(3B). 2333–7. 14 indexed citations
2.
Sidoni, Angelo, Antonio Cavaliere, Guido Bellezza, et al.. (2006). Coexpression of HER-2/neu and p53 in Breast Cancer Identifies a Subset with an Aggressive Biopathological Profile. Tumori Journal. 92(5). 412–415. 5 indexed citations
3.
Bucciarelli, E, Angelo Sidoni, Guido Bellezza, et al.. (2006). Low dentin matrix protein 1 expression correlates with skeletal metastases development in breast cancer patients and enhances cell migratory capacity in vitro. Breast Cancer Research and Treatment. 105(1). 95–104. 18 indexed citations
4.
Colozza, Mariantonietta, Angelo Sidoni, Anna Maria Mosconi, et al.. (2005). HER2 Overexpression as a Predictive Marker in a Randomized Trial Comparing Adjuvant Cyclophosphamide/Methotrexate/5-Fluorouracil with Epirubicin in Patients with Stage I/II Breast Cancer: Long-Term Results. Clinical Breast Cancer. 6(3). 253–259. 19 indexed citations
5.
Sidoni, Angelo, Antonio Cavaliere, Guido Bellezza, Massimo Scheibel, & E Bucciarelli. (2003). Breast cancer in young women: clinicopathological features and biological specificity. The Breast. 12(4). 247–250. 106 indexed citations
6.
Sidoni, Angelo, Guido Bellezza, Antonio Cavaliere, et al.. (2003). Prognostic indexes in breast cancer: comparison of the Nottingham and Adelaide indexes. The Breast. 13(1). 23–27. 10 indexed citations
7.
Sidoni, Angelo, Lorenza Pistola, Guido Bellezza, et al.. (2003). Evaluation of the Prognostic Role of Vascular Endothelial Growth Factor and Microvessel Density in Stages I and II Breast Cancer Patients. Breast Cancer Research and Treatment. 81(2). 159–168. 78 indexed citations
8.
Gregorc, Vanesa, Vienna Ludovini, Lorenza Pistola, et al.. (2002). Relevance of p53, bcl-2 and Rb expression on resistance to cisplatin-based chemotherapy in advanced non-small cell lung cancer. Lung Cancer. 39(1). 41–48. 35 indexed citations
9.
Sidoni, Angelo, et al.. (2001). Biopathological significance of single cell DNA aneuploidy measured by static cytometry in breast cancer. The Breast. 10(4). 325–329. 12 indexed citations
10.
Bellezza, Guido, Angelo Sidoni, E Bucciarelli, et al.. (2000). Biological prognostic factors for early stage completely resected non-small cell lung cancer. Lung Cancer. 29(1). 133–133. 1 indexed citations
11.
Cavaliere, Antonio, Angelo Sidoni, Ivana Ferri, Rino Vitali, & E Bucciarelli. (1999). Computer-assisted immunocytochemical determination of breast cancer steroid receptors on cytological smears of excised surgical specimens compared with frozen sections. Cytometry. 38(6). 301–305. 10 indexed citations
12.
Barbati, Antonella, Angelo Sidoni, Paola Collini, et al.. (1997). Value of c-erbB-2 and p53 oncoprotein co-overexpression in human breast cancer.. PubMed. 17(1A). 401–5. 19 indexed citations
13.
Sidoni, Angelo & E Bucciarelli. (1997). Ciliated Cyst of the Perineal Skin. American Journal of Dermatopathology. 19(1). 93–96. 21 indexed citations
14.
Falini, Brunangelo, Arcangelo Liso, Laura Pasqualucci, et al.. (1997). CD30+ anaplastic large‐cell lymphoma, null type, with signet‐ring appearance. Histopathology. 30(1). 90–92. 32 indexed citations
15.
16.
17.
Soares, Janine, Gorana Tomasic, Vincenzo Eusebi, & E Bucciarelli. (1994). Intralobular growth of myoepithelial cell carcinoma of the breast. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 425(2). 205–10. 22 indexed citations
18.
Bucciarelli, E. (1973). [Pulmonary adenomatosis of the sheep (Jaagsiekte). Ultrastructural study].. PubMed. 33(3). 99–117. 4 indexed citations
19.
Biancifiori, C, et al.. (1967). The Action of Oestrone and Four Chemical Carcinogens in Intact and Ovariectomised BALB/c/Cb/Se Mice. British Journal of Cancer. 21(2). 452–459. 3 indexed citations
20.
Biancifiori, C, et al.. (1964). Induction of Hepatomas in CBA/Cb/Se Mice by Hydrazine Sulphate and the Lack of Effect of Croton Oil on Tumour Induction in BALB/c/Cb/Se Mice. British Journal of Cancer. 18(3). 543–550. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Larry Kluskens Breakdown of academic impact, for papers by K Mukai Breakdown of academic impact, for papers by Black Mm Breakdown of academic impact, for papers by E. L. Jones Breakdown of academic impact, for papers by Paul Drillenburg Breakdown of academic impact, for papers by Frank B. Fromowitz Breakdown of academic impact, for papers by Torben Schiødt Breakdown of academic impact, for papers by Melek Ergin Breakdown of academic impact, for papers by Abelardo Moreno Breakdown of academic impact, for papers by Anita Borges
Rankless by CCL
2026